HERB KOSTEN PANCREATIC CANCER CHARITABLE FUND (EIN 861129030) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

ALAN KOSTEN

Phone

9016065330

Tax Period

2025-01-01 to 2025-12-31

HERB KOSTEN PANCREATIC CANCER CHARITABLE FUND, founded in 2010, is a small nonprofit in the Medical Research sector that reported $285K in total revenue in fiscal year 2025. Revenue surged 32% from the prior year, signaling strong growth momentum. Expenses of $245K left a modest 14% surplus.

Mission

THE CHARITY SEEKS PUBLIC CONTRIBUTIONS TO FURTHER RESEARCH IN THE STUDY OF PANCREATIC CANCER, ITS CAUSES AND POTENTIAL CURES. GRANTS ARE MADE TO UNIVERSITIES AND RESEARCH GROUPS TO SEEK CANCER CURES FOR PANCREATIC CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $312,618

Program Service Revenue $0

Investment Income $10,388

Other Revenue $-38,356

TOTAL REVENUE $284,650

Expense Breakdown

Grants Paid $195,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $222,675

Other Expenses $49,925

TOTAL EXPENSES $244,925

Year-over-Year Comparison

	2025	2024	Change
Revenue	$284,650	$215,102	+0.3%
Expenses	$244,925	$238,797	+0.0%
Net Income	$39,725	$-23,695	-2.7%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ALAN KOSTEN	PRESIDENT	5.00	Director	$0	$0	$0
JEFFREY GOLDBERG	SEC/TRESURER	2.00	Director	$0	$0	$0
LORIE KOSTEN	VP	0.50	Director	$0	$0	$0
JULIE KOSTEN	CHAIRMAN	2.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$284,650	$244,925	$465,975	$39,725
2024	No data	No data	No data	No data
2023	$260,644	$121,612	$449,945	$139,032
2022	$225,605	$228,773	$310,913	$-3,168
2021	$160,097	$233,780	$314,081	$-73,683
2020	$174,660	$235,545	$387,764	$-60,885
2019	$170,252	$41,547	$448,649	$128,705
2018	$111,005	$200,895	$319,944	$-89,890

HERB KOSTEN PANCREATIC CANCER CHARITABLE FUND